HALO logo
halo search icon
BeOne Medicines Ltd. Sponsored ADR
BeOne Medicines Ltd. Sponsored ADR
ONC · NAS

BeOne Medicines Ltd. Sponsored ADR

US$308.74

Price Arrow11.73 (3.95%)
20/05/2026 04:00:00 PM
All-ConsensusConsensus CheapEngulfing Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BeOne Medicines Ltd. Sponsored ADR Overview

ONC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ONC

icon

Telephone

41.61.685.19.00

icon

Address

Aeschengraben 27, Basel, Basel-Landschaft (Basle Country) 4051

Description

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

ONC Price Chart

Key Stats

Market Cap

US$35.89B

PE

119.80

EV/EBITDA

53.9

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 232.78 - 385.22

Trade Value (12mth)

US$22,710,990.00

1 week

1.28%

1 month

-4.9%

YTD

-4.5%

1 year

25.59%

All time high

426.56

Key Fundamentals

EPS 3 yr Growth

-113.60%

EBITDA Margin

11.00%

Operating Cashflow

$1,131m

Free Cash Flow Return

23.10%

ROIC

5.90%

Interest Coverage

10.10

Quick Ratio

3.10

Other Data

Shares Outstanding (Fully Diluted)

116m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ONC Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
06 May 26
06 May 26
06 May 26

ONC Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-8.44-6.132.64locklocklock
EPS (Fully Diluted)
$locklocklocklock-8.44-6.132.54locklocklock
Growth
%locklocklocklock56.527.4143.1locklocklock
PE
XlocklocklocklockN/AN/A119.8locklocklock
EV/EBITDA
XlocklocklocklockN/AN/A53.9locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of BeOne Medicines Ltd. Sponsored ADR (ONC:NAS)?
Halo FAQ
The current share price of BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) is USD$308.74.
What is the 52-week high share price for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS)?
Halo FAQ
The 52-week high share price for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) is USD$385.22.
What is the 52-week low share price for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS)?
Halo FAQ
The 52-week low share price for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) is USD$232.78.
What is the dividend yield for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS)?
Halo FAQ
BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) does not pay a dividend.
What was BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) last dividend payment?
Halo FAQ
BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) does not pay a dividend.
What is the franking level for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS)?
Halo FAQ
BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) has a franking level of 0.00%.
In which sector is BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) classified?
Halo FAQ
BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS)?
Halo FAQ
The current P/E ratio for BeOne Medicines Ltd. Sponsored ADR (ONC:NAS) is 119.80.

See beyond the curve.

One solution for research, investing and portfolio management.